(S)-2-oxoimidazolidine-4-carboxylic acid, 95.0%, 5g

methyl 2-oxoacetate hydrate, 95.0%, 1g

5-Methyl-2-pyridin-3-yl-thiazole-4-carboxylic acid, 95.0%, 1g

Ethyl 6-(Chloroformyl)hexanoate>97.0%(GC)(T)5g

p-Butoxybenzylidene p-Pentylaniline, 98.0%, 5g

5-Hidroximetilfurfural, mínimo 97 %, para síntesis, 250 mg, envase de vidrio

(1R,2S)-2-Aminocyclopentanol hydrochloride, 95.0%, 5g

1,4-Bis(2-chloroethyl)benzene>96.0%(GC)1g

4-Benzyloxazolidine-2,5-dione, 95.0%, 10g

2-Amino-5-chloroquinazoline, 95.0%, 1g

2-(IMIDAZOL-2-YL)-PYRIDINE, 97.0%, 5g

2-(5-chlorobenzo[d]isoxazol-3-yl)acetic acid, 95.0%, 250mg

[4-(3-Chlorophenyl)-tetrahydro-2H-pyran-4-yl]methanamine, 250mg